Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need, visits the Nasdaq MarketSite in Times Square in celebration of its initial public offering (IPO).
Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need, visits the Nasdaq MarketSite in Times Square in celebration of its initial public offering (IPO).